Wednesday, April 15, 2026
HomeTagsInsilico Medicine

Tag: Insilico Medicine

Healthcare

Insilico Medicine and Lilly Announce Global R&D Deal

AI-driven collaboration includes an exclusive worldwide license for a portfolio of programs spanning multiple therapeutic areas. Insilico Medicine, a clinical-stage biotechnology company powered by generative...
Healthcare

Insilico Medicine and Servier Forge Up to US$888 Million Multi-Year Oncology R&D Collaboration

Fresh off its landmark December 2025 listing on the Hong Kong Stock Exchange, Insilico Medicine has inked a multi-year R&D collaboration with global pharma...
Healthcare

Insilico Medicine Raises $110M Series E for AI Drug Discovery

Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced that it has successfully secured a $110 million Series E financing led...
Healthcare

Harbour BioMed & Insilico Medicine Collaborate on AI Antibody Discovery

Harbour BioMed, a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immunology and oncology, and Insilico...
Healthcare

For the First Time, Quantum-Enhanced Generative AI Generates Viable Cancer Drug Candidates

The research demonstrates a breakthrough in applying quantum-enhanced generative AI to drug discovery using today’s quantum devices. Zapata Computing, Inc., the Industrial Generative AI company,...

Recent Published

About Us

Discover the future of artificial intelligence at AITech365. Explore the latest AI news, delve into insightful interviews with industry experts, and stay informed about the most exciting and trending topics shaping the world of AI.

Latest

Popular

Quick Link

© 2026 AITech365. All Rights Reserved. Website Undertaking: Data Demand